IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CGEM

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents78.6475.0888.33103.3472.8276.6683.01102.09115.0274.2398.4364.85141.83122.13156.15242.66353.5676.1259.7788.11
Short-term Investments255.90276.80289.56229.26192.66227.17315.97475.99547.47358.78368.63401.58349.96268.57311.14333.29257.43238.74230.69232.94
Total Current Assets341.97361.41386.76342.24275.91317.77414.67592.04677.80445.72480.19476.71498.24399.03474.47582.08622.84322.31296.56328.84
Property, Plant & Equipment0.260.340.420.490.570.610.680.760.840.910.991.071.161.241.170.790.050.060.080.09
Total Non-current Assets*21.8141.5861.62141.89244.42261.91207.1661.223.423.713.9918.0023.75115.9686.6535.1644.41115.15140.62124.57
Total Assets363.79402.98448.37484.13520.33579.68621.82653.25681.22449.43484.18494.71521.98514.99561.12617.24667.25437.46437.19453.40
Accounts Payable3.732.510.841.722.463.401.682.121.563.712.490.952.492.032.661.523.106.313.172.02
Total Current Liabilities40.6335.1537.7432.7628.0627.3530.6524.2023.4821.9328.1423.4419.6826.1722.5027.1262.0417.2611.757.86
Total Non-current Liabilities*1.411.661.900.000.130.490.851.191.521.842.152.452.733.173.593.990.600.740.070.07
Total Liabilities42.0336.8139.6432.7628.1827.8431.5025.3925.0023.7730.2925.8922.4129.3426.0931.1162.6317.9911.817.93
Retained Earnings(691.48)(637.78)(588.12)(537.41)(486.80)(416.74)(368.24)(320.59)(280.03)(238.00)(200.86)(177.05)(137.87)(105.66)(47.69)(20.91)3.89(171.01)(158.91)(126.39)
Total Stockholder Equity*321.75366.17408.73451.37492.15551.84590.33627.86656.22425.67453.70468.82499.57485.65535.03586.13604.54418.70424.97443.39
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue----------------------------0.000.000.000.000.0018.94
Research & Development44.4442.1242.9541.9761.0341.4640.4935.5136.2630.6534.8533.8227.3952.1021.3219.6826.4124.5420.8812.68
Selling, General & Admin12.8211.5712.3113.6314.7713.5414.5613.3513.7712.3410.6410.9810.2110.6611.2910.0910.708.1213.475.70
Total Operating Expenses57.2553.7055.2655.6075.8055.0055.0548.8650.0342.9945.4944.8037.6062.7632.6129.7737.1132.6634.3518.38
Operating Income(57.25)(53.70)(55.26)(55.59)(75.80)(55.00)(55.05)(48.85)(50.03)(42.99)(45.48)(45.24)(37.60)(62.76)(32.61)(29.77)239.68(32.66)(34.35)(18.37)
Pretax Income--------------------(39.68)(39.18)(32.21)(58.14)(28.95)(27.41)240.14(32.46)----
Tax Provision--------------------(14.12)0.000.000.00(1.86)(2.52)66.07(19.57)--0.00
Net Income(53.70)(49.66)(50.71)(50.61)(70.06)(48.50)(47.65)(40.56)(42.03)(37.15)(23.80)(39.18)(32.21)(57.96)(26.78)(24.80)174.90(12.10)(32.51)(17.35)
Basic EPS--------------(0.69)(0.75)(0.86)(0.54)(0.91)(0.82)(1.42)(0.61)(0.54)3.90------
Diluted EPS--------------(0.69)(0.75)(0.86)(0.54)(0.91)(0.82)(1.42)(0.58)(0.54)3.77------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(38.22)(46.04)(38.11)(36.88)(57.61)(43.15)(36.63)(34.14)(36.29)(38.25)(18.13)(34.14)(31.01)(51.00)(24.98)(54.35)(25.42)(21.91)(15.17)(10.55)
Capital Expenditures----0.010.04----0.000.000.000.000.000.000.050.160.880.25-----0.000.00
Free Cash Flow*----(38.12)(36.91)----(36.63)(34.14)(36.29)(38.25)(18.13)(34.14)(31.05)(51.16)(25.86)(54.60)----(15.17)(10.55)
Investing Cash Flow40.6832.4122.3967.3953.4036.8115.9619.88(185.11)12.9651.47(42.96)12.1115.18(28.61)(57.98)300.8534.71(15.86)(25.59)
Financing Cash Flow1.100.380.720.000.370.001.581.33262.201.090.250.1138.601.79(32.91)1.432.013.542.700.58
← Scroll for more columns →

* Derived from reported values